C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/864 (2006.01) A61K 38/16 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2720097
Disclosed are tyrosine-modified rAAV vectors, as well as infectious virions, compositions, and pharmaceutical formulations that comprise them. Also disclosed are methods of preparing and methods for using the disclosed tyrosine-phosphorylated capsid protein mutant rAAV vectors in a variety of diagnostic and therapeutic applications including in vivo and ex vivo gene therapy, and large-scale production of rAAV vectors.
L'invention concerne des vecteurs rAAV modifiés par la tyrosine, ainsi que des virions infectieux, des compositions et des formulations pharmaceutiques qui les comprennent. L'invention concerne également des procédés de préparation et des procédés d'utilisation desdits vecteurs rAAV mutants à protéines de capside phosphorylées par la tyrosine dans une pluralité d'applications diagnostiques et thérapeutiques, y compris la thérapie génique in vivo et ex vivo, ainsi que la production à large échelle de vecteurs rAAV.
Agbandje-Mckenna Mavis
Govindasamy Lakshmanan
Srivastava Arun
Zhong Li
Zolotukhin Sergei
Gowling Lafleur Henderson Llp
University Of Florida Research Foundation Inc.
LandOfFree
Raav vector compositions having tyrosine-modified capsid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Raav vector compositions having tyrosine-modified capsid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Raav vector compositions having tyrosine-modified capsid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1894679